Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$168.05
Price-1.66%
-$2.83
1Y
Price
Market Cap
$8.271b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+21.4%
EBITDA Margin+5.1%
Net Profit Margin+16.4%
Free Cash Flow MarginRevenue
$4.029b
-0.5%
1y CAGR+0.5%
3y CAGR+3.4%
5y CAGREarnings
-$69.225m
-772.3%
1y CAGR-290.8%
3y CAGR-212.0%
5y CAGREPS
-$1.33
-765.0%
1y CAGR-288.5%
3y CAGR-210.2%
5y CAGRBook Value
$3.400b
$7.561b
Assets$4.161b
Liabilities$2.786b
DebtDebt to Assets
36.9%
5.3x
Debt to EBITDAFree Cash Flow
$578.495m
+15.3%
1y CAGR+25.5%
3y CAGR+8.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company